Siteman Cancer Center at Washington University Treats 2,000th Patient with MRIdian MRI-Guided Radiation Therapy
| VRAYDelisted Stock | USD 0.04 0 5.67% |
Slightly above 62% of ViewRay's investor base is looking to short. The analysis of current outlook of investing in ViewRay suggests that many traders are alarmed regarding ViewRay's prospects. ViewRay's investing sentiment can be driven by a variety of factors including economic data, ViewRay's earnings reports, geopolitical events, and overall market trends.
ViewRay |
ViewRay, Inc. announced today that the clinical team at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis has treated its 2,000th patient using the MRIdian, MRI-guided radiation therapy system. Patients treated at Siteman Cancer Center benefit from MRIdians diagnostic quality MR visualization on-table adaptive radiotherapy, real-time tissue tracking, and automated beam control. In January 2014, Siteman Cancer Center became t
Read at finance.yahoo.com
 |
ViewRay Fundamental Analysis
We analyze ViewRay's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ViewRay using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ViewRay based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
ViewRay is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
ViewRay Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ViewRay stock to make a market-neutral strategy. Peer analysis of ViewRay could also be used in its relative valuation, which is a method of valuing ViewRay by comparing valuation metrics with similar companies.
Peers
ViewRay Related Equities
| BBLG | Bone Biologics | 5.56 | ||||
| HSCS | Heart Test | 2.17 | ||||
| ATEC | Alphatec Holdings | 0.11 | ||||
| AVNS | Avanos Medical | 0.62 | ||||
| DCTH | Delcath Systems | 0.84 | ||||
| AXGN | Axogen | 1.49 | ||||
| INGN | Inogen | 1.63 | ||||
| AORT | Artivion | 1.74 | ||||
| SGHT | Sight Sciences | 2.49 | ||||
| OFIX | Orthofix Medical | 2.69 | ||||
| ESTA | Establishment Labs | 2.81 | ||||
| ANIK | Anika Therapeutics | 3.30 | ||||
| CVRX | CVRx | 4.77 | ||||
| VVOS | Vivos Therapeutics | 6.24 | ||||
| NPCE | Neuropace | 6.26 | ||||
| TIVC | Tivic Health | 7.60 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in ViewRay Stock
If you are still planning to invest in ViewRay check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ViewRay's history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |